Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000456673 | SCV000558151 | likely benign | Hypertrophic cardiomyopathy | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620639 | SCV000736887 | likely benign | Cardiovascular phenotype | 2017-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001185257 | SCV001351432 | likely benign | Cardiomyopathy | 2019-09-04 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001613301 | SCV001471090 | likely benign | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001358769 | SCV001554641 | likely benign | not specified | 2021-03-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001613301 | SCV001837074 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000456673 | SCV004836638 | likely benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing |